Skip to main content
. 2016 Mar 24;7(18):25493–25506. doi: 10.18632/oncotarget.8333

Figure 4. Impact of ACL on OS in patients with different scores.

Figure 4

(A–C) OS of ACL and non-ACL patients with the score of 0–5, 6–9, and ≥ 10, in the primary cohort; (D–F): OS of ACL and non-ACL patients with the score of 0–5, 6–9, and ≥ 10, in the validation cohort.